$HRTX HERON THERAPEUTICS, INC. /DE/ Insiders
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in HERON THERAPEUTICS, INC. /DE/.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of current and past insiders in HERON THERAPEUTICS, INC. /DE/. Find out how many shares they currently own, their value and whether they buy or sell their shares.
HERON THERAPEUTICS, INC. /DE/ Insiders
| Name | Position | Total Shares | Current Value ($) | Last 3 Months | Buy / Sell | Last Transaction | |
|---|---|---|---|---|---|---|---|
| 14159 capital (GP), LLC | 10% Owner | 0 | 0 | Apr 26 2011 | |||
| ADAM MICHAEL A | COO | 0 | 0 | Jul 12 2011 | |||
| ADAM MICHAEL A | Chief Operating Officer | 0 | 0 | Feb 12 2013 | |||
| Baker Bros. Capital (GP), LLC | 10% Owner | 0 | 0 | Apr 26 2011 | |||
| Baker Bros. Capital (GP), LLC | 10% Owner | 0 | 0 | Jul 05 2011 | |||
| Baker Brothers Life Sciences Capital (GP), LLC | 10% Owner | 0 | 0 | Apr 26 2011 | |||
| Baker Brothers Life Sciences Capital (GP), LLC | 10% Owner | 5,266,568 | 70,308,683 | Jul 05 2011 | |||
| BARR JOHN | Vice President of R&D | 51,772 | 691,156 | Jul 12 2011 | |||
| BARR JOHN | Sr VP of R & D | 0 | 0 | Jan 17 2008 | |||
| Christian Waage | Director | 4,100 | 54,735 | Apr 16 2021 | |||
| Clendeninn Neil James | SVP & Chief Medical Officer | 0 | 0 | Oct 13 2015 | |||
| DAVIS STEPHEN | Director | 3,000 | 40,050 | Dec 23 2020 | |||
| DAVIS STEPHEN | Director | 95,891 | 1,280,145 | Feb 22 2011 | |||
| DAVIS STEPHEN | Director | 20,076 | 268,015 | Dec 15 2014 | |||
| Drazba Brian G. | VP, Finance & CFO | 3,260 | 43,521 | Dec 23 2016 | |||
| Drazba Brian G. | VP, Finance & CFO | 818 | 10,920 | Dec 15 2014 | |||
| DRURY STEPHEN A | Director | 83,283 | 1,111,828 | Aug 14 2006 | |||
| Gelder Mark S. MD | SVP & Chief Medical Officer | 0 | 0 | Dec 15 2014 | |||
| Gelder Mark S. MD | SVP & Chief Medical Officer | 0 | 0 | Mar 28 2014 | |||
| GODDARD PAUL | Director | 18,250 | 243,638 | May 31 2012 | |||
| GODDARD PAUL | Director | 34,750 | 463,913 | May 30 2008 | |||
| GODDARD PAUL | Director | 214,683 | 2,866,018 | Jul 12 2011 | |||
| HOFFMAN ROBERT | CFO & SVP, Finance | 1,280 | 17,088 | Dec 23 2019 | |||
| Johnson Craig A | Director | 3,590 | 47,927 | Apr 07 2021 | |||
| Johnson Craig A | Director | 0 | 0 | Dec 15 2014 | |||
| MANHARD KIMBERLY | EVP, Drug Development | 2,067 | 27,594 | Apr 15 2021 | |||
| MANHARD KIMBERLY | Director | 0 | 0 | Dec 15 2014 | |||
| Marshall Paul | SVP, Technical Operations | 2,200 | 29,370 | Mar 23 2016 | |||
| Marshall Paul | SVP, Technical Operations | 0 | 0 | Dec 15 2014 | |||
| OCONNELL MICHAEL | Chief Executive Officer | 132,200 | 1,764,870 | Jan 12 2006 | |||
| Peraza Lisa | VP, Chief Accounting Officer | 12,136 | 162,016 | Apr 15 2021 | |||
| POYHONEN JOHN | President & CCO | 20,847 | 278,307 | Apr 15 2021 | |||
| POYHONEN JOHN | Director | 0 | 0 | Dec 15 2014 | |||
| PRENTKI RONALD J | President & CEO | 0 | 0 | Jul 09 2008 | |||
| PRENTKI RONALD J | President & CEO | 40,539 | 541,196 | Feb 19 2010 | |||
| Quart Barry D | Chief Executive Officer | 600 | 8,010 | Apr 15 2021 | |||
| Quart Barry D | Chief Executive Officer | 52,868 | 705,788 | Dec 15 2014 | |||
| Retzios Anastassios D. | V.P. of Clinical Development | 0 | 0 | Nov 22 2006 | |||
| Retzios Anastassios D. | VP of Clinical Development | 0 | 0 | Jan 17 2008 | |||
| RIEPENHAUSEN PETER | Director | 36,270 | 484,205 | May 24 2007 | |||
| RIEPENHAUSEN PETER | Director | 9,000 | 120,150 | May 30 2008 | |||
| Rosen Robert | President | 132,109 | 1,763,655 | Dec 18 2018 | |||
| ROSENBLATT TOBY | Director | 210,234 | 2,806,624 | May 26 2010 | |||
| ROSENBLATT TOBY | Director | 37,182 | 496,380 | May 30 2008 | |||
| ROSENBLATT TOBY | Director | 0 | 0 | Nov 12 2008 | |||
| SPCH, LLLP | 10% Owner | 38,095,238 | 508,571,427 | Sep 12 2012 | |||
| Szekeres David Leslie | EVP, Chief Operating Officer | 1,250 | 16,688 | Apr 15 2021 | |||
| TANG KEVIN C | Director | 5,799,810 | 77,427,464 | Dec 23 2019 | |||
| TANG KEVIN C | Director | 60,436,506 | 806,827,355 | Jul 12 2011 | |||
| TANG KEVIN C | Director | 4,596,318 | 61,360,845 | Dec 16 2014 | |||
| TAYLOR ARTHUR T | Director | 12,000 | 160,200 | May 25 2007 | |||
| TAYLOR ARTHUR T | Director | 12,000 | 160,200 | May 30 2008 | |||
| TURNBULL GREG | Director | 245,092 | 3,271,978 | Jul 12 2011 | |||
| TURNBULL GREG | President & CEO | 51,159 | 682,973 | Nov 29 2007 | |||
| TURNBULL GREG | CEO, President & Interim CFO | 65,159 | 869,873 | May 30 2008 | |||
| TURNBULL GREG | Director | 0 | 0 | May 31 2012 | |||
| Whelan John | CFO | 254,088 | 3,392,075 | Jul 19 2013 | |||
| WHITEFORD STEPHEN | V.P., Finance & CFO | 15,000 | 200,250 | Dec 18 2006 | |||
| WINGER DENNIS L | Director | 69,544 | 928,412 | Aug 14 2006 | |||
| ZERBE ROBERT L MD | Director | 22,139 | 295,556 | May 30 2008 | |||
| ZERBE ROBERT L MD | Director | 202,072 | 2,697,661 | May 26 2010 |